StockData
CannaPharmaRx, Inc. logo

CannaPharmaRx, Inc. (CPMD) income statement

CPMDOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 17, 2026Score 1/30
$0.00+0.00 (0.00%)

Close on Oct 16, 2026Market cap $2.54MP/E –Yield –

CannaPharmaRx, Inc. income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, TTM

Gross margin
-130.7%
Operating margin
-210.8%
Net margin
-779.2%
Return on equity, FY2025
44.6%

Financial strength

Current ratio
0.05
Debt to equity
–
Debt to assets
–
Cash to current liabilities
0.1%

Valuation

P/E ratio
–
Price to sales
2.15
Price to book
–
Dividend yield
–

See a number that looks wrong?